October marks the start of a new fiscal year for the USPTO. Last week the agency announced the extension of several pilot programs that will continue on into 2023 and beyond.
The Caner Immunotherapy Pilot Program/Patents 4 Patients program has been extend through January 31, the Fast-Track Appeals Pilot Program has been extended through July 2, 2024, and the After Final Consideration Pilot AFCP Program 2.0 has been extended to September 30, 2023